Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1/2 8Phase 1 5Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 34Glioblastoma 8Glioma 7Meningeal Carcinomatosis 6Epilepsy 5Neuroblastoma 4Neoplasms 4Neoplasm Metastasis 4Pituitary Neoplasms 3Meningioma 3Melanoma 3Lung Neoplasms 3Breast Neoplasms 3Seizures 2Retinoblastoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Paraganglioma 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 1 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Delirium 2Central Nervous System Diseases 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Wilms Tumor 1Stroke 1

Interventions

Sodium Chloride 2Dexmedetomidine 2Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Central Nervous System Diseases × CNS × Clear all
NCT04399343 2021-01-28

DEPOD

Capital Medical University

Phase 4 Unknown
700 enrolled
CNS

Central Nervous System Diseases, Delirium

NCT04494828 2021-01-12

Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor

Capital Medical University

Phase 4 Completed
60 enrolled
CNS

Central Nervous System Diseases, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡